Market Overview

A Peek Into The Market Before The Trading Starts

Related EV
UPDATE: Keefe, Bruyette & Woods Reiterates On Eaton Vance Following In-Line Results
UPDATE: Eaton Vance FQ3 Profit Beats Estimates
Related AUXL
Benzinga's Top Downgrades
UBS Downgrades Auxilium Pharmaceuticals To Neutral

Pre-open movers US stock futures are higher this morning, as investors are awaiting weekly jobless claims data. Futures for the Dow Jones Industrial Average surged 34 points to 12,500.00 and S&P 500 index futures rose 4.50 points to 1,320.20. Nasdaq 100 futures gained 9.25 points to 2,549.75.

A Peek Into Global Markets European markets were higher today. The STOXX Europe 600 Index rose 1.02%, London's FTSE 100 Index gained 1.52%, French CAC 40 index rose 0.98% and German DAX 30 index climbed 0.81%.

Asian markets ended mostly lower, with Japan's Nikkei Stock Average rising 0.08%, Chinese Shanghai Composite declining 0.53% and Australia's S&P/ASX 200 dropping 0.31%. Hong Kong's Hang Seng index fell 0.64% and India's Sensex surged 1.84%.

Broker Recommendation Analysts at Citigroup upgraded Eaton Vance Corp (NYSE: EV) from “sell” to “neutral.” The target price for Eaton Vance has been lowered from $24 to $23.50.

Eaton Vance shares fell 0.91% to close at $23.98 yesterday.

Breaking news

  • Auxilium Pharmaceuticals Inc (NASDAQ: AUXL) and FCB I LLC announced today that they filed a lawsuit against Watson Laboratories, Inc. (NV); Watson Pharmaceuticals, Inc. (NYSE: WPI); and Watson Pharma, Inc. for infringement of FCB's ten patents listed in the U.S. Food and Drug Administration's Approved Drug Products with Therapeutic Equivalence Evaluations as covering Testim® 1% testosterone gel. To read the full news, click here.
  • Ku6 Media Co Ltd (NASDAQ: KUTV) today announced that it has entered into an agreement with famous Chinese SNS website ("Kaixin001"). To read the full news, click here.
  • Cepheid (NASDAQ: CPHD) today announced that the U.S. Food & Drug Administration (FDA) has cleared its GeneXpert® Infinity-80 System, a high-throughput automated molecular system designed to deliver around-the-clock results for a wide variety of clinical testing applications. To read the full newsclick here.
  • Wesco Aircraft Holdings Inc (NYSE: WAIR) today announced that it has entered into an agreement to acquire substantially all of the assets of Interfast Inc. for CDN$134 million in cash. To read the full news, click here.

Posted-In: Citigroup US Stock FuturesNews Futures Global Pre-Market Outlook Markets


Related Articles (AUXL + CPHD)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters